Canada has conditionally approved Leqembi (lecanemab), the first treatment that targets an underlying cause of early Alzheimer’s disease by removing...
A study from the University of Tsukuba in Japan has found that routine exercise helps ward off cognitive impairment in older adults – and exercising with...
New research from King’s College London has established a blood-based test that could be used to predict the risk of Alzheimer’s disease up to three and...
Impact-Site-Verification: 141fda33-6be1-44b7-9ec8-c6d00d4c4a8e
The acquisition expands CareAcademy’s ability to serve a broader healthcare ecosystem in home and community settings.
Lithuanian researchers from Kaunas University of Technology (KTU) attempted to identify early symptoms of Parkinson’s disease using voice data with the help of AI. More than...
The Parkinson’s Foundation has reached a significant milestone with the recruitment, genetic testing and counselling of 7,500 participants in its international gene study. Currently at 50...
